FitLife Brands Inc (NASDAQ: FTLF) is a nutrition industry company that develops, markets, and sells dietary supplement and nutritional supplement products. Revenue is transactional, generated through the sale of finished supplement products containing vitamins, minerals, amino acids, herbs, botanicals, fruits, berries, and other dietary substances. The company competes in the supplements segment of the broader nutrition industry, which also includes natural and organic foods, functional foods, and natural and organic personal care and household products. FTLF began trading on the Nasdaq Capital Market on September 18, 2023. The company effected a 2-for-1 stock split of its Common Stock on February 7, 2025. Operations extend beyond the United States, with products sold in international markets including certain European countries subject to EU regulations, and other markets requiring ministry of health approvals. The company operates as a single reporting unit as of the FY2025 10-K filed March 31, 2026.

Revenue model

Transactional revenue from the sale of dietary supplement and nutritional supplement products. Products are classified as dietary supplements under DSHEA in the United States. No subscription or licensing revenue model is disclosed in the filing excerpts.

Products and services

Nutritional supplement products formulated with vitamins, minerals, amino acids, herbs, botanicals, fruits, berries, and other dietary substances. Products are classified as dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Specific brand names are not disclosed in the filing excerpts.

Customers and end markets

End consumers in the nutrition and dietary supplement market. The company identifies key demand drivers as aging populations, rising healthcare costs, preventative medicine trends, and growing public awareness of the diet-health connection. Specific customer concentration data is not disclosed in the filing excerpts.

Value-chain role

Manufacturer and marketer of dietary supplement products, responsible for product formulation, manufacturing, packaging, distribution, importing, exporting, and storage. The company holds trademarks, service marks, and website URLs as part of its brand equity. Regulatory approvals in international markets may be secured directly or through distributors depending on the country.

Geographic exposure

United States is the primary market. The company also operates in international markets including European countries subject to EU regulations and other markets requiring ministry of health approvals or certifications. Specific revenue breakdown by geography is not disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-03-31

Industry: Medicinal Chemicals & Botanical Products Peers: LFTD Partners Inc ALTEROLA BIOTECH INC. BioForce Nanosciences Holdings Inc LifeMD Inc Estee Lauder Companies Inc Upexi, Inc Healing Co Inc. Nature's Sunshine Products Inc Thorne Healthtech, Inc.